ACETYLCYSTEINE SOLUTION USP
Google image searchProduct monograph
Active ingredient
acetylcysteine, 200 MG/ML
DIN: 02459906
Dosage form(s): SOLUTION
Route(s) of administration: INHALATION, INTRAVENOUS, ORAL
Schedule: Ethical
Company: HIKMA CANADA LIMITED
Date: 13-JUN-2023
ATC:
- R05 — COUGH AND COLD PREPARATIONS (ATC, ATC/DDD, )
- R05C — EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS (ATC, ATC/DDD)
- R05CB — Mucolytics (ATC, ATC/DDD)
- R05CB01 — ACETYLCYSTEINE (ATC/DDD)
Reference brand drug: Mucomyst, Parvolex
Pharmaceutical standard: USP
